{"mainPropery":{"diseaseId":1121,"diseaseName":"Carnitine palmitoyltransferase 2 deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1121/carnitine-palmitoyltransferase-2-deficiency","synonyms":["Carnitine palmitoyltransferase deficiency type 2","CPT2","Carnitine palmitoyltransferase II (CPT II) deficiency"],"synonyms-with-source":[{"name":"Carnitine palmitoyltransferase deficiency type 2"},{"name":"CPT2"},{"name":"Carnitine palmitoyltransferase II (CPT II) deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"600650"},{"identifierType":"ORPHANET","identifierId":"157"},{"identifierType":"UMLS","identifierId":"C0342790"}]},"diseaseCategories":[{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":175,"resourceName":"FOD (Fatty Oxidation Disorder) Family Support Group","abbreviation":"","address1":"P.O. Box 54","address2":"","address3":"","address4":"","address5":"","city":"Okemos","state":"MI","zip":"48805-0054","country":"United States","phone":"+1-517-381-1940 [8am - 8pm EST every day]","tty":"","tollFree":"","fax":"+1-866-290-5206","email":"deb@fodsupport.org","url":"https://fodsupport.org/","freeText":""},{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":694,"resourceName":"MitoAction","abbreviation":"","address1":"PO Box 51474","address2":"","address3":"","address4":"","address5":"","city":"Boston","state":"MA","zip":"02205","country":"United States","phone":"1-888-MITO-411 (648-6411) for support line","tty":"","tollFree":"1-888-648-6228","fax":"","email":"info@mitoaction.org","url":"https://www.mitoaction.org/","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/600650' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Carnitine+palmitoyltransferase+2+deficiency' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Carnitine palmitoyltransferase 2 deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Carnitine+palmitoyl+transferase+2+deficiency%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Carnitine palmitoyltransferase 2 deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://www.ghr.nlm.nih.gov/condition=carnitinepalmitoyltransferaseiideficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Carnitine palmitoyltransferase 2 deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/carnitine-palmitoyltransferase-type-ii-deficiency' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":834,"resourceId":1515,"resourceName":"Carnitine palmitoyltransferase 2 deficiency","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/CPT-II ' target='_blank'>Newborn Screening Coding and Terminology Guid</a>e created by the National Library of Medicine (NLM) at the National Institutes of Health (NIH) promotes and facilitates the use of electronic health data standards in recording and transmitting newborn screening test results. The Web site includes standard codes and terminology for newborn tests and conditions for which they screen, and links to related sites. Click on the link to view details for this condition. ","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1324,"resourceId":1985,"resourceName":"Newborn screening - AAP Carnitine palmitoyl","descriptionText":"Simone Albers, et al.  <a href='http://pediatrics.aappublications.org/cgi/reprint/107/6/e103?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=10&amp;amp;RESULTFORMAT=&amp;amp;fulltext=carnitine&amp;amp;searchid=1&amp;amp;FIRSTINDEX=0&amp;amp;volume=107&amp;amp;issue=6&amp;amp;resourcetype=HWCIT ' target='_blank'>Detection of Neonatal Carnitine Palmitoyltransferase II Deficiency by Expanded Newborn Screening With Tandem Mass Spectrometry</a>.  <em>Pediatrics</em>, Jun 2001;107:e103.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1397,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled <a href='https://clinicaltrials.gov/ct2/show/NCT02769949' target='_blank'>Pediatric Patients With Metabolic or Other Genetic Disorders</a>&nbsp;which may be of interest to you.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=157' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=cpt2' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1547,"resourceId":2175,"resourceName":"Screening, Technology And Research in Genetics (STAR-G) Project","descriptionText":"The <a href='http://www.newbornscreening.info/Parents/fattyaciddisorders/CPT2.html' target='_blank'>Screening, Technology And Research in Genetics (STAR-G) Project</a> has a fact sheet on this condition, which was written specifically for families that have received a diagnosis as a result of newborn screening. This fact sheet provides general information about the condition and answers questions that are of particular concern to parents.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_LongChainFatOxidation-enPro8768.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0060235' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6220,"questionText":"What is carnitine palmitoyltransferase 2 (CPT 2) deficiency?","answerText":"<strong>Carnitine palmitoyltransferase&nbsp;2 (CPT2) deficiency</strong> is a condition that prevents the body from using certain fats for energy, particularly during periods without food (fasting). There are three main types of CPT2 deficiency: a lethal neonatal form, a severe infantile hepatocardiomuscular form, and a myopathic form.[5245] The&nbsp;neonatal and infantile forms&nbsp;are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia (extremely low levels of ketones (substances produced when fat cells break down in the blood) and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000386.htm\" target=\"_blank\">low blood sugar</a>), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001105.htm\" target=\"_blank\">cardiomyopathy</a>, seizures, and early death. The myopathic form is&nbsp;characterized by exercise-induced muscle pain and weakness and occasional&nbsp;myoglobinuria (rust-colored urine indicating breakdown of muscle tissue).[5246] Mutations in the <span class=\"geneSymbol\"><em><a href=\"http://www.ghr.nlm.nih.gov/gene/CPT2\" target=\"_blank\">CPT2</a></em></span> gene cause CPT2 deficiency. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[5245] Treatment is based on avoidance of prolonged fasting and a low-fat and high-carbohydrate diet.[5247]&nbsp;&nbsp;","dateModified":"2012-05-29T16:53:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13715,"phenoTypeName":"Reduced carnitine O-palmitoyltransferase level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15611,"phenoTypeName":"Decreased plasma free carnitine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1584,"phenoTypeName":"Decreased plasma total carnitine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9657,"phenoTypeName":"Elevated plasma acylcarnitine levels","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6230,"phenoTypeName":"Exercise intolerance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5304,"phenoTypeName":"Exercise-induced myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14535,"phenoTypeName":"Hyperlipidemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4321,"phenoTypeName":"Myoglobinuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14500,"phenoTypeName":"Myopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13958,"phenoTypeName":"Red-brown urine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13568,"phenoTypeName":"Cold-induced muscle cramps","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14338,"phenoTypeName":"Episodic abdominal pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5287,"phenoTypeName":"Exercise-induced muscle cramps","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13235,"phenoTypeName":"Intermittent painful muscle spasms","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6215,"phenoTypeName":"Renal tubular epithelial necrosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14503,"phenoTypeName":"Rhabdomyolysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7355,"phenoTypeName":"Stage 5 chronic kidney disease","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13072,"phenoTypeName":"Tubulointerstitial nephritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13816,"phenoTypeName":"Abnormality of the basal ganglia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8733,"phenoTypeName":"Agenesis of corpus callosum","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9406,"phenoTypeName":"Cerebellar vermis hypoplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14302,"phenoTypeName":"Cerebral calcification","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14169,"phenoTypeName":"Cystic renal dysplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10203,"phenoTypeName":"Hepatic calcification","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5685,"phenoTypeName":"Hepatic failure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9825,"phenoTypeName":"Hydrocephalus","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13092,"phenoTypeName":"Hypoketotic hypoglycemia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13809,"phenoTypeName":"Neonatal respiratory distress","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9389,"phenoTypeName":"Pachygyria","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10044,"phenoTypeName":"Polycystic kidney dysplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13744,"phenoTypeName":"Polymicrogyria","frequencyText":"Very rare","percentRanges":"1%-4%"}],"medicalProducts":[],"EncodedName":"Carnitine_palmitoyltransferase_2_deficiency"}